Brad Benson, Ph.D. Brad Benson, Ph.D., is an accomplished pharmaceutical scientist and executive who brings both CRO and sponsor perspectives to the biopharmaceutical development process. A 36-year veteran of the pharmaceutical industry, Dr. Benson is an expert in GLP and CGMP requirements, and has extensive experience with regulatory filings in the United States and Europe. In addition to program design services, Dr. Benson offers technical consultation in various areas of expertise, including characterization of biopharmaceutical products, licensing agreements and manufacturing processes. Ask Brad Key Qualifications Over 15 years of method development experience Managed process development and analytical sciences for inhalation products to treat cystic fibrosis, asthma and COPD Managed lab activities of biotechnology, bioanalytical, analytical, microbiology and Phase 1 clinics in the United States and Germany Leadership experience from development-stage to well established biopharmaceutical companies Experience in biomarker assay development, technology transfer and corporate collaborations Expertise in protein biotechnology including all types of HPLC analysis and purification of proteins, amino acid analysis, mass spectrometry and peptide chemistry Experience in molecular biology and cell biology